Welcome!
Medicines Co.
M&A
Novartis agrees to buy Medicines Co. in US$6.8 bil deal
(Nov 25): Novartis AG agreed to buy Medicines Co. for an equity value of about US$6.8 billion ($9.3 billion), snapping up a promising cholesterol drug and adding to a string of acquisitions for Chief Executive Officer Vas Narasimhan.
November 25, 2019